Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 1
2014 1
2015 1
2018 2
2019 2
2020 4
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
Management of Cancer-associated Thrombosis (CAT): Symptomatic or Incidental.
Papakotoulas P, Tsoukalas N, Christopoulou A, Ardavanis A, Koumakis G, Papandreou C, Papatsimpas G, Papakostas P, Samelis G, Andreadis C, Aravantinos G, Ziras N, Kalofonos C, Samantas E, Souggleri M, Makrantonakis P, Pentheroudakis G, Athanasiadis A, Stergiou H, Tripodaki S, Bokas A, Grivas A, Timotheadou E, Bournakis E, Varthalitis I, Boukovinas I. Papakotoulas P, et al. Among authors: grivas a. Anticancer Res. 2020 Jan;40(1):305-313. doi: 10.21873/anticanres.13954. Anticancer Res. 2020. PMID: 31892581
Real-World Data on Thromboprophylaxis in Active Cancer Patients: Where Are We? Are We Getting There?
Tsoukalas N, Papakotoulas P, Christopoulou A, Ardavanis A, Koumakis G, Papandreou C, Papatsimpas G, Papakostas P, Samelis G, Andreadis C, Aravantinos G, Ziras N, Kalofonos C, Samantas E, Souggleri M, Makrantonakis P, Pentheroudakis G, Athanasiadis A, Stergiou H, Tripodaki ES, Bokas A, Grivas A, Timotheadou E, Bournakis E, Varthalitis I, Boukovinas I. Tsoukalas N, et al. Among authors: grivas a. Cancers (Basel). 2020 Jul 15;12(7):1907. doi: 10.3390/cancers12071907. Cancers (Basel). 2020. PMID: 32679747 Free PMC article.
CYP2E1 and risk of chemically mediated cancers.
Trafalis DT, Panteli ES, Grivas A, Tsigris C, Karamanakos PN. Trafalis DT, et al. Among authors: grivas a. Expert Opin Drug Metab Toxicol. 2010 Mar;6(3):307-19. doi: 10.1517/17425250903540238. Expert Opin Drug Metab Toxicol. 2010. PMID: 20073996 Review.
Plerixafor-aided Mobilization of Peripheral Blood Hematopoietic Stem Cells to Support Subsequent High-dose Chemotherapy After a Prior Autologous Transplant.
Fergadis E, Assi A, Kranidioti E, Kosma A, Karakosta M, Miltiadous C, Dimitriadis GK, Grivas A, Athanasopoulos A, Lianos E, Kosmas C. Fergadis E, et al. Among authors: grivas a. Clin Lymphoma Myeloma Leuk. 2020 Feb;20(2):e50-e57. doi: 10.1016/j.clml.2019.11.022. Epub 2019 Dec 6. Clin Lymphoma Myeloma Leuk. 2020. PMID: 31884151
Re-mobilization of hematopoietic progenitors for further autografting after prior myelo-ablative high-dose chemotherapy and autologous hematopoietic stem cell transplantation; the role of plerixafor.
Kosmas C, Kranidioti E, Kosma A, Karakosta M, Miltiadous C, Grivas A, Athanasopoulos A, Lianos E. Kosmas C, et al. Among authors: grivas a. Leuk Lymphoma. 2019 Jul;60(7):1819-1822. doi: 10.1080/10428194.2018.1543879. Epub 2019 Jan 8. Leuk Lymphoma. 2019. PMID: 30618317 No abstract available.
Real-World Data on Health-Related Quality of Life Assessment in Patients With Breast Cancer Receiving Subcutaneous Trastuzumab.
Syrios J, Pappa E, Volakakis N, Grivas A, Alafis J, Manioudaki S, Tzouda V, Korogiannos A, Rapti C, Koufopoulos N, Nikolaidou A, Kanavou E, Alexopoulos A, Koumarianou A. Syrios J, et al. Among authors: grivas a. Breast Cancer (Auckl). 2018 Feb 20;12:1178223418758031. doi: 10.1177/1178223418758031. eCollection 2018. Breast Cancer (Auckl). 2018. PMID: 29511355 Free PMC article.
An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with Afatinib in Real-World Clinical Settings in Greece.
Mountzios G, Lampaki S, Koliou GA, Vozikis A, Kontogiorgos I, Papantoniou P, Koufaki MI, Res E, Boutis A, Christopoulou A, Pastelli N, Grivas A, Aravantinos G, Lalla E, Oikonomopoulos G, Koumarianou A, Spyratos D, Bafaloukos D, Rigakos G, Papakotoulas P, Fountzilas G, Linardou H. Mountzios G, et al. Among authors: grivas a. Lung Cancer (Auckl). 2021 Aug 30;12:93-102. doi: 10.2147/LCTT.S318007. eCollection 2021. Lung Cancer (Auckl). 2021. PMID: 34512058 Free PMC article.
Thymic carcinoma: what after disease progression?
Syrios J, Diamantis N, Panou M, Grivas A, Lianos E, Karvounis N, Athanasiou AE. Syrios J, et al. Among authors: grivas a. J BUON. 2014 Apr-Jun;19(2):581-2. J BUON. 2014. PMID: 24965430 No abstract available.
13 results